Your browser doesn't support javascript.
loading
Advantages of FBPA PET in evaluating early response of anti-PD-1 immunotherapy in B16F10 melanoma-bearing mice: Comparison to FDG PET.
Tatsumi, Mitsuaki; Soeda, Fumihiko; Naka, Sadahiro; Kurimoto, Kenta; Ooe, Kazuhiro; Fukui, Hideyuki; Katayama, Daisuke; Watabe, Tadashi; Kato, Hiroki; Tomiyama, Noriyuki.
Afiliación
  • Tatsumi M; Department of Radiology, Osaka University Hospital, Suita, Osaka,  Japan.
  • Soeda F; Department of Nuclear Medicine and Tracer Kinetics, Osaka University Graduate School of Medicine, Suita, Osaka,  Japan.
  • Naka S; Department of Nuclear Medicine and Tracer Kinetics, Osaka University Graduate School of Medicine, Suita, Osaka,  Japan.
  • Kurimoto K; Department of Nuclear Medicine and Tracer Kinetics, Osaka University Graduate School of Medicine, Suita, Osaka,  Japan.
  • Ooe K; Department of Nuclear Medicine and Tracer Kinetics, Osaka University Graduate School of Medicine, Suita, Osaka,  Japan.
  • Fukui H; Department of Radiology, Osaka University Graduate School of Medicine, Suita, Osaka,  Japan.
  • Katayama D; Department of Nuclear Medicine and Tracer Kinetics, Osaka University Graduate School of Medicine, Suita, Osaka,  Japan.
  • Watabe T; Department of Nuclear Medicine and Tracer Kinetics, Osaka University Graduate School of Medicine, Suita, Osaka,  Japan.
  • Kato H; Department of Nuclear Medicine and Tracer Kinetics, Osaka University Graduate School of Medicine, Suita, Osaka,  Japan.
  • Tomiyama N; Department of Radiology, Osaka University Hospital, Suita, Osaka,  Japan.
Front Oncol ; 12: 1026608, 2022.
Article en En | MEDLINE | ID: mdl-36620558

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article